GK Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$296K Buy
+6,182
New +$266K 0.16% 160
2025
Q4
Sell
-6,086
Closed -$311K 210
2025
Q3
$338K Buy
+6,086
New +$356K 0.25% 97
2025
Q2
Sell
-3,205
Closed -$218K 166
2025
Q1
$223K Sell
3,205
-519
-14% -$42.9K 0.25% 118
2024
Q4
$320K Buy
+3,724
New +$403K 0.41% 74

Other funds holding NVO

GK Wealth Management's NVO Position: Q2 2026 in Review

GK Wealth Management opened a new position in Novo Nordisk (NVO) in Q2 2026: 6,182 shares worth $296K. The stake represents 0.16% of the portfolio and ranks #160 among its holdings. This is a return to the name: GK Wealth Management previously reported a position in NVO as recently as Q3 2025.

GK Wealth Management first reported a position in NVO in Q4 2024 and has held it in 4 quarters since. The position peaked at $338K in Q3 2025. 387 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • GK Wealth Management held 6,182 shares of Novo Nordisk worth $296K as of Q2 2026.
  • Novo Nordisk was a new GK Wealth Management position in Q2 2026.
  • Novo Nordisk made up 0.16% of GK Wealth Management's portfolio in Q2 2026, its #160 holding.
  • GK Wealth Management first reported a position in Novo Nordisk in Q4 2024 and has held it in 4 quarters since.
  • GK Wealth Management's Novo Nordisk position peaked at $338K in Q3 2025.
  • 387 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on GK Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.